Meyfroidt, G;
Gunst, J;
Martin-Loeches, I;
Smith, M;
Robba, C;
Taccone, FS;
Citerio, G;
(2019)
Management of the brain-dead donor in the ICU: general and specific therapy to improve transplantable organ quality.
Intensive Care Medicin
, 45
(3)
pp. 343-353.
10.1007/s00134-019-05551-y.
Preview |
Text
Smith_Management of the brain-dead donor in the ICU_AAM.pdf - Accepted Version Download (455kB) | Preview |
Abstract
PURPOSE: To provide a practical overview of the management of the potential organ donor in the intensive care unit. METHODS: Seven areas of donor management were considered for this review: hemodynamic management; fluids and electrolytes; respiratory management; endocrine management; temperature management; anaemia and coagulation; infection management. For each subchapter, a narrative review was conducted. RESULTS AND CONCLUSIONS: Most elements in the current recommendations and guidelines are based on pathophysiological reasoning, epidemiological observations, or extrapolations from general ICU management strategies, and not on evidence from randomized controlled trials. The cardiorespiratory management of brain-dead donors is very similar to the management of critically ill patients, and the same applies to the management of anaemia and coagulation. Central diabetes insipidus is of particular concern, and should be diagnosed based on clinical criteria. Depending on the degree of vasopressor dependency, it can be treated with intermittent desmopressin or continuous vasopressin, intravenously. Temperature management of the donor is an area of uncertainty, but it appears reasonable to strive for a core temperature of > 35 °C. The indications and controversies regarding endocrine therapies, in particular thyroid hormone replacement therapy, and corticosteroid therapy, are discussed. The potential donor should be assessed clinically for infections, and screening tests for specific infections are an essential part of donor management. Although the rate of infection transmission from donor to receptor is low, certain infections are still a formal contraindication to organ donation. However, new antiviral drugs and strategies now allow organ donation from certain infected donors to be done safely.
| Type: | Article |
|---|---|
| Title: | Management of the brain-dead donor in the ICU: general and specific therapy to improve transplantable organ quality |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1007/s00134-019-05551-y |
| Publisher version: | https://doi.org/10.1007/s00134-019-05551-y |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions. |
| Keywords: | Organ procurement, Brain, Brain Death, Family, Hemodynamics, Humans, Intensive Care Units, Organ Preservation, Tissue and Organ Procurement |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > UCL BEAMS UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science > Dept of Med Phys and Biomedical Eng |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10102541 |
Archive Staff Only
 |
View Item |
